BioNMR Group

Welcome to the Lee BioNMR Research Lab Page!

The focus of our group is to investigate connections between the function, structure, and dynamics of biomolecules using Nuclear Magnetic Resonance (NMR) spectroscopy.

Click here to learn more about our work.

We're at the CTR Building, HSC Campus, University of Louisville, KY!

Most Recent Featured Publication

First ever structure (PDB:6NUI) of the human guanylate kinase, the only known enzyme responsible for cellular GDP production, is solved by our group in collaboration with, and led by the Sabo group (Medicine). We also show potential for GMPK as an important drug discovery target for lung cancer.

Click here for a complete list of publications.

Recent Lab News

Doctoral candidate, Mark, successfully defends his dissertation proposal and is now completely in the research phase of his program! He is also currently mentoring UL Biology undergrad, Sidi, through a UL Mentored Research and Creative Activities Grant. Meanwhile, former intern and R25 trainee, Alicia, continues her stint at the lab as an undergraduate visiting scholar.

The lab is awarded two EVPRI Internal Grants for A.Y. 2019-2020, which will allow us to explore new projects involving protein-drug interactions. Stay tuned to learn more!

Featured On-Campus Collaborations at the University of Louisville

Bioengineering: The Lee group assisted the laboratory of Dr. Jill Steinbach-Rankins of the Department of Bioengineering in characterizing their electrospun fibers formulated as a delivery system. Our paper, "pH-Responsive Delivery of Griffithsin from Electrospun Fibers," has now been accepted for publication in the European Journal of Pharmaceutics and Biopharmaceutics. We are always open for collaborations in a wide range of fields where NMR spectroscopy can be applied. Do not hesitate to contact us or drop by our lab!

Medicine/Brown Cancer Center: Through collaborations with multiple labs across the James Graham Brown Cancer Center, particularly the Sabo lab, we deliver the first structure of human guanylate kinase. Studies in lung cancer cell lines additionally reveal the potential of hGMPK as an important molecular target. Check out the paper here. Also check out the research of the other teams: Dr. Levi Beverly, Dr. John Trent, Dr. Manfred Konrad (MPI-BC), and Dr. Mike Sabo.